The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, February 11, 2019
The FDA has cleared the IND application for PRGN-3005, a first-in-class investigational therapy using autologous CAR-T cells to treat advanced-stage ...
read more
Friday, February 08, 2019
Antidote Therapeutics has entered into a collaboration with the National Cancer Institute (NCI) to further develop its lead compound, ATI-1013, to a ...
read more
Tuesday, February 05, 2019
AstraZeneca Pharmaceuticals, MedImmune LLC
AstraZeneca and MedImmune, announced the FDA has granted Breakthrough Therapy Designation for MEDI8897, an extended half-life respiratory syncytial ...
read more
Monday, February 04, 2019
Neurana Pharmaceuticals has enrolled its first patient in the "STAR Study," a Phase 2 dose ranging study of tolperisone in acute muscle spasms of the ...
read more
Q BioMed announced its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
read more
Thursday, January 24, 2019
Inovio announced a second patient with HPV-related head and neck cancer treated with INO-3112 achieved full remission after subsequent treatment with ...
read more
Tuesday, January 22, 2019
I-Mab Biopharma announced the IND application for the initiation of a Phase 1 clinical study for TJD5 in patients with advanced solid tumor has ...
read more
Aerpio announced the completion of patient dosing in the TIME-2b study to assess the efficacy and safety of AKB-9778 for non-proliferative diabetic ...
read more
Thursday, January 17, 2019
Actelion has received a complete response letter from the FDA for its sNDA for OPSUMIT (macitentan) in the treatment of adults with inoperable chronic...
read more
Daiichi Sankyo announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy ...
read more
SIRION Biotech has signed a license and collaboration agreement with Denali Therapeutics, a biopharmaceutical company developing product candidates ...
read more
Thursday, January 10, 2019
OncoImmune has completed its Phase IIa trial of CD24Fc for the Prevention of Acute GVHD Following Myeloablative Allogeneic HSCT.
read more
Tuesday, January 08, 2019
Novartis announced the FDA has granted crizanlizumab Breakthrough Therapy designation for the prevention of vaso-occlusive crises in patients of all ...
read more
Eli Lilly and Company and Loxo Oncology announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or ...
read more
Friday, December 28, 2018
The FDA has approved VAXELIS for use in children from 6 weeks through 4 years of age. VAXELIS was developed as part of a joint partnership between ...
read more